Georg Schlechtingen

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents. Top assignees: Gri Bio, Inc., Glycoregimmune, Inc., Jado Technologies Gmbh. Active years: 2009-2026.

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 90.9

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Cologne, DE (2017)
Dresden, DE (2009 - 2023)

Company Filing History:

Jado Technologies Gmbh

patents

4. 1 out of 1,330

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

5. 1 out of 100

Technische Universitát Dresden

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528775 - Oxygenated and amino- or ammonium-containing phosphonic acid derivatives and their medical use (2026-01-20),

2. 11564895 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2023-01-31),

3. 11453642 - Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2022-09-27),

4. 10952977 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2021-03-23),

5. 10829506 - Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2020-11-10),

6. 10815195 - Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2020-10-27),

7. 10143668 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2018-12-04),

8. 9850265 - Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2017-12-26),

9. 9751834 - Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2017-09-05),

10. 9573886 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2017-02-21),

11. 7629385 - Sphingolipid-derived pharmaceutical compositions (2009-12-08),

Title: Georg Schlechtingen: Innovator in Medical Chemistry

Introduction

Georg Schlechtingen is a prominent inventor based in Dresden, Germany. He has made significant contributions to the field of medical chemistry, holding a total of 11 patents. His work focuses on developing innovative compounds that have potential medical applications.

Latest Patents

One of Schlechtingen's latest patents is titled "Hydroxy-substituted amino and ammonium derivatives and their medical use." This invention relates to hydroxy-substituted amino and ammonium derivatives, particularly the compounds of formula 1 or 2. These compounds are intended for use in the treatment, prevention, or amelioration of inflammatory, autoimmune, and allergic disorders, as well as proliferative, neoplastic, or dysplastic diseases.

Another notable patent is "Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use." This invention concerns oxygenated amino and ammonium-containing derivatives, specifically the compounds of formula 1, 2, 3, 4, 5, or 6. Similar to his previous work, these compounds are aimed at addressing inflammatory, autoimmune, and allergic disorders, along with various neoplastic diseases.

Career Highlights

Throughout his career, Georg Schlechtingen has worked with several companies, including Gri Bio, Inc. and Glycoregimmune, Inc. His expertise in medical chemistry has allowed him to contribute to the development of innovative solutions in the healthcare sector.

Collaborations

Schlechtingen has collaborated with notable professionals in his field, including Tim Friedrichson and Gary Jennings. These partnerships have further enhanced his research and development efforts.

Conclusion

Georg Schlechtingen is a distinguished inventor whose work in medical chemistry has led to significant advancements in the treatment of various diseases. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.